EATG » Hepatitis

Hepatitis

Many European countries are not ready to stop viral hepatitis

Patient groups from 25 European countries participated in the Hep-CORE study Many European countries lack a comprehensive policy to eliminate viral hepatitis as a major public health threat, according to…

Hepatitis C-infected heart and lung transplants safe

Hearts and lungs from people infected with hepatitis C are safe for transplantation because the virus can be effectively treated in the recipient, new data show. The cure for hepatitis C infection…

News from The International Liver Congress 2018

The International Liver Congress™ 2018 (ILC 2018) took place on 11-15 April 2018 in Paris, France. It is an annual congress, organized by The European Association for the Study of…

Treating hepatitis C and HIV coinfections in injecting drug users

In 2016, an estimated 2.3 million people living with HIV were coinfected with chronic hepatitis C virus (HCV). Of the coinfected population, more than half were intravenous drug users (IVDUs).…

News from The International Liver Congress 2018

The International Liver Congress™ 2018 (ILC 2018) is taking place from 11-15 April 2018 in Paris, France. It is an annual congress, organized by The European Association for the Study…

ILC 2018: New affordable hepatitis C combination shows 97% cure rate

The combination of sofosbuvir and the new NS5A inhibitor ravidasvir cured 97% of people with hepatitis C in a study carried out in Malaysia, and could provide a safe and…

ILC 2018: Atea Pharmaceuticals reports positive proof of concept clinical data with AT-527 for the treatment of chronic hepatitis C

-- AT-527 is a novel pan-genotypic purine nucleotide prodrug NS5B polymerase inhibitor which has been safe and well tolerated in this ongoing multiple part trial -- AT-527 exhibits potent antiviral…

Sensitive new assay detects hepatitis B infection in single liver cells and serum

Technique measuring the cccDNA marker may allow earlier detection of hepatocellular carcinoma in patients, reports The Journal of Molecular Diagnostics Philadelphia, April 12, 2018 - Chronic hepatitis B virus (HBV)…

Ending hepatitis C means including people who inject drugs

With affordable, highly-effective hepatitis C (HCV) direct acting antiretroviral medications now available, innovative programs in San Francisco are reaching people who inject drugs with hepatitis C cure support and treatment.…

8 reports on liver cancer outcomes with HCV, DAA therapy

Patients with hepatitis C have an increased risk for disease progression to cirrhosis and potentially hepatocellular carcinoma. Recent studies have focused on defining liver cancer risks related to HCV progression…

1 2 3 75